1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, multicenter, phase II study of ipatasertib (Ipat, GDC-0068), an inhibitor of Akt, in combination with paclitaxel (Pac) as front-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC)
    Meeting Abstract

    Isakoff, S. J.; Kim, S. B.; Im, S. A.; Dent, R. A.; Traina, T. A.; Valero, V.; Saura, C.; Yalamanchili, S.; Patel, P.; Oliveira, M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+breast cancer treated on CALGB (Alliance) 40601 and 40603
    Meeting Abstract

    Iglesia, M. D.; Vincent, B. G.; Serody, J. S.; Carey, L. A.; Barry, W. T.; Sikov, W. M.; Hudis, C. A.; Winer, E. M.; Perou, C. M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
    Meeting Abstract

    Hoadley, K. A.; Barry, W. T.; Pitcher, B. N.; Parker, J. S.; Wilkerson, M. D.; Irvin, W.; Henry, N. L.; Tolaney, S. M.; Dang, C.; Krop, I. E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • The extent of lobular carcinoma in situ (LCIS) at surgical excision predicts for the development of subsequent breast cancer
    Meeting Abstract

    Gooch, J. C.; Guerini Rocco, E.; Patil, S.; Koslow, S. B.; De Brot, M.; Park, A. Y.; Boafo, C. A.; Reis, J. S.; King, T. A.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of breast cancer treatment with adjuvant chemotherapy or tamoxifen alone on ovarian reserve
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M.; Moy, F.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Risk of infectious complications in breast cancer patients treated with trastuzumab: A meta-analysis
    Meeting Abstract

    Funakoshi, T.; Suzuki, M.; Muss, H. B.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer
    Meeting Abstract

    Forero, A.; Burris, H.; LoRusso, P.; Specht, J.; Miller, K.; Mita, M.; Liu, M. C.; Modi, S.; Pusztai, L.; Sussman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Determining the role of somatic ERa mutations in acquired hormone (or SERM) resistance
    Meeting Abstract

    Fanning, S. W.; Mayne, C.; Toy, W.; Shen, Y.; Sharma, A.; Panchamukhi, S.; Nowak, J.; Nettles, K. W.; Chandarlapaty, S.; Katzenellenbogen, J. A.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • The development of a prediction tool for moderate to severe diarrhea in HER-2/hormone positive metastatic breast cancer (MBC) patients receiving lapatinib in combination with letrozole (L-L)
    Meeting Abstract

    Dranitsaris, G.; Lacouture, M. E.
    Cancer Research (2015)

    Fulltext@MSK | Save